Inspire Medical Systems, Inc. (NYSE:INSP) Stock Position Increased by Eversept Partners LP

Eversept Partners LP grew its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) by 6.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 294,302 shares of the company's stock after acquiring an additional 18,032 shares during the quarter. Inspire Medical Systems comprises approximately 4.8% of Eversept Partners LP's investment portfolio, making the stock its 4th largest holding. Eversept Partners LP owned about 0.98% of Inspire Medical Systems worth $54,558,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. First Horizon Advisors Inc. boosted its holdings in Inspire Medical Systems by 885.7% in the fourth quarter. First Horizon Advisors Inc. now owns 138 shares of the company's stock valued at $26,000 after purchasing an additional 124 shares during the last quarter. Huntington National Bank lifted its holdings in shares of Inspire Medical Systems by 228.3% in the 4th quarter. Huntington National Bank now owns 174 shares of the company's stock valued at $32,000 after buying an additional 121 shares during the period. Harbour Investments Inc. boosted its stake in shares of Inspire Medical Systems by 101.0% in the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company's stock worth $37,000 after buying an additional 99 shares during the last quarter. AlphaQuest LLC raised its position in Inspire Medical Systems by 7,275.0% during the fourth quarter. AlphaQuest LLC now owns 295 shares of the company's stock valued at $55,000 after acquiring an additional 291 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its holdings in Inspire Medical Systems by 61.9% in the fourth quarter. Quadrant Capital Group LLC now owns 327 shares of the company's stock valued at $61,000 after acquiring an additional 125 shares during the period. 94.91% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

INSP has been the topic of a number of analyst reports. KeyCorp dropped their price objective on shares of Inspire Medical Systems from $234.00 to $216.00 and set an "overweight" rating on the stock in a research note on Monday. Truist Financial cut their price objective on shares of Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating for the company in a report on Tuesday, February 11th. Royal Bank of Canada dropped their target price on Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Stifel Nicolaus cut their price target on Inspire Medical Systems from $190.00 to $175.00 and set a "hold" rating for the company in a research note on Monday. Finally, Wells Fargo & Company lowered their price target on Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating on the stock in a research report on Tuesday, February 11th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $218.90.

Inspire Medical Systems Stock Up 0.5 %

Shares of Inspire Medical Systems stock traded up $0.77 during trading hours on Friday, reaching $158.97. 315,939 shares of the company's stock were exchanged, compared to its average volume of 583,912. The business has a fifty day moving average of $163.29 and a two-hundred day moving average of $181.75. The company has a market capitalization of $4.73 billion, a P/E ratio of 91.89, a price-to-earnings-growth ratio of 2.86 and a beta of 1.39. Inspire Medical Systems, Inc. has a 1 year low of $123.00 and a 1 year high of $257.40.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings data on Monday, February 10th. The company reported $1.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. As a group, research analysts predict that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Insider Buying and Selling at Inspire Medical Systems

In related news, insider Randy Ban sold 25,584 shares of the firm's stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the completion of the sale, the insider now directly owns 7,259 shares of the company's stock, valued at approximately $1,332,026.50. This trade represents a 77.90 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CTO John Rondoni sold 583 shares of the company's stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the completion of the transaction, the chief technology officer now directly owns 10,424 shares in the company, valued at $1,777,187.76. The trade was a 5.30 % decrease in their position. The disclosure for this sale can be found here. 4.10% of the stock is currently owned by company insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.